Farringdon Capital’s Bio-Techne TECH Stock Holding History

Farringdon Capital’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-4,154	Closed	-$299K	–	588
2024 Q4	$299K	Buy	+4,154	New	+$305K	0.12%	286

Other funds holding TECH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Farringdon Capital's TECH Position: Q1 2025 in Review

Farringdon Capital sold out of Bio-Techne (TECH) in Q1 2025, closing a stake of 4,154 shares — an estimated $299K sold.

Farringdon Capital first reported a position in TECH in Q4 2024 and held it in 1 quarter. The position peaked at $299K in Q4 2024. 577 funds tracked by Wall St. Rank hold TECH as of Q1 2025.

Farringdon Capital reported no remaining Bio-Techne position as of Q1 2025 after selling out during the quarter.
Farringdon Capital sold 4,154 Bio-Techne shares in Q1 2025, an estimated $299K.
Farringdon Capital first reported a position in Bio-Techne in Q4 2024 and held it in 1 quarter.
Farringdon Capital's Bio-Techne position peaked at $299K in Q4 2024.
577 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2025.

Based on Farringdon Capital's 13F filing for Q1 2025, filed 15 May 2025.